RxDoctor Payments Data

Odrick Rosas

Physical Medicine & Rehabilitation · Toa Alta, PRNPI 1477940500

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AstraZeneca at 24.2% of the total. Reporting peaked in 2019 at $687 and has fallen 81.8% since, to $125 in 2023. Among physical medicine & rehabilitation clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,026in general payments, 2019–2025

Across 14 payments — averaging $73.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$248
  • Johnson & Johnson$240
  • Ferring Pharmaceuticals Inc.$125
  • Sanofi-aventis U.S. LLC$100
  • Tanabe Pharma America, Inc.$96
  • Merck$78
  • plus $140 from 4 others

What the payments were for

  • Food & beverage$1,026100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,026 in reported general payments places this provider in the 95th percentile of 156 physical medicine & rehabilitation providers in Puerto Rico.

See all physical medicine & rehabilitation providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$8,064
Medicare patients
24
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium ErDiclofenac Sodium71$2,974
Diclofenac Potassium58$1,731
Triamcinolone Acetonide72$728
Dexamethasone89$690
Sulindac46$494
Diclofenac Sodium39$459
Meloxicam79$338
Celecoxib19$284
Duloxetine Hcl19$244
Methylprednisolone26$235
Nabumetone12$140
Gabapentin24$134
Tramadol Hcl21$69

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Toa Alta

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →